Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCHW) Equity Average (2022 - 2025)

Historic Equity Average for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$18.8 million.

  • Envoy Medical's Equity Average fell 2125.13% to -$18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.8 million, marking a year-over-year decrease of 2125.13%. This contributed to the annual value of -$10.3 million for FY2024, which is 4570.07% up from last year.
  • Latest data reveals that Envoy Medical reported Equity Average of -$18.8 million as of Q3 2025, which was down 2125.13% from -$27.0 million recorded in Q2 2025.
  • Envoy Medical's 5-year Equity Average high stood at $1.5 million for Q4 2023, and its period low was -$46.3 million during Q2 2023.
  • Over the past 4 years, Envoy Medical's median Equity Average value was -$19.8 million (recorded in 2022), while the average stood at -$20.8 million.
  • Per our database at Business Quant, Envoy Medical's Equity Average skyrocketed by 10562.13% in 2023 and then tumbled by 134202.66% in 2024.
  • Envoy Medical's Equity Average (Quarter) stood at -$26.8 million in 2022, then surged by 105.62% to $1.5 million in 2023, then tumbled by 1342.03% to -$18.7 million in 2024, then fell by 0.36% to -$18.8 million in 2025.
  • Its Equity Average was -$18.8 million in Q3 2025, compared to -$27.0 million in Q2 2025 and -$21.5 million in Q1 2025.